Characteristics and prognosis of COVID-19 patients with hematological diseases in Japan

Characteristics and prognosis in COVID-19 patients with hematologic diseases in Japan: a cross-sectional study - JSH-COVID19-20

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044254

Enrollment

100

Registered

2021-05-19

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological diseases, coronavirus disease 2019

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients who have been registered or will be registered in the future into the Epidemiological Survey "Hematological Disease Registration" in the Japanese Society of Hematology (2) Patients who were diagnosed as COVID19 infection (SARS-CoV-2 PCR-positive or antigen-positive), and whose prognosis up to 2 months after diagnosis has been fixed. (Suspected patients in imaging or antibody test are not included.)

Exclusion criteria

Exclusion criteria: (1) When the subject is judged inappropriate in this study by the principal investigator or subinvestigators. (2) When the subject or his/her substitute requests to decline the research cooperation.

Design outcomes

Primary

Measure	Time frame
Evaluation of characteristics and short-term prognosis of COVID-19 patients with hematological diseases in Japan	—

Countries

Japan

Contacts

Public ContactDaisuke Minakata

Jichi Medical University Division of Hematology

daisuke_minakata_kappa@yahoo.co.jp0285-58-7353

Outcome results